Frequencies for first 10,000 rows of indi_pt variable in indi2017q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdomen scan | 1 0.01 0.01 Abdominal discomfort | 8 0.08 0.09 Abdominal pain | 5 0.05 0.14 Abnormal behaviour | 11 0.11 0.25 Acquired immunodeficiency syndrome | 9 0.09 0.34 Acquired oesophageal web | 3 0.03 0.37 Acral overgrowth | 3 0.03 0.40 Acromegaly | 8 0.08 0.48 Acute coronary syndrome | 9 0.09 0.57 Acute leukaemia | 1 0.01 0.58 Acute lymphocytic leukaemia | 12 0.12 0.70 Acute myeloid leukaemia | 38 0.38 1.08 Acute promyelocytic leukaemia | 52 0.52 1.60 Adjustment disorder | 6 0.06 1.66 Adrenal insufficiency | 1 0.01 1.67 Adverse drug reaction | 1 0.01 1.68 Affective disorder | 27 0.27 1.95 Age-related macular degeneration | 4 0.04 1.99 Aggression | 2 0.02 2.01 Agitation | 10 0.10 2.11 Agoraphobia | 1 0.01 2.12 Alcohol use | 1 0.01 2.13 Allergic sinusitis | 2 0.02 2.15 Allergy prophylaxis | 2 0.02 2.17 Allergy to chemicals | 6 0.06 2.23 Alopecia | 10 0.10 2.33 Anaemia | 14 0.14 2.47 Anaemia of malignant disease | 2 0.02 2.49 Anaemia prophylaxis | 3 0.03 2.52 Analgesic therapy | 14 0.14 2.66 Anaphylactic reaction | 2 0.02 2.68 Androgen replacement therapy | 17 0.17 2.85 Androgenetic alopecia | 2 0.02 2.87 Aneurysm | 1 0.01 2.88 Angina pectoris | 2 0.02 2.90 Angiomyolipoma | 2 0.02 2.92 Angiopathy | 1 0.01 2.93 Ankylosing spondylitis | 6 0.06 2.99 Anti-neutrophil cytoplasmic antibody .. | 2 0.02 3.01 Antiallergic therapy | 1 0.01 3.02 Antibiotic prophylaxis | 10 0.10 3.12 Antibiotic therapy | 2 0.02 3.14 Anticoagulant therapy | 16 0.16 3.30 Antidepressant therapy | 6 0.06 3.36 Antifungal prophylaxis | 6 0.06 3.42 Antiinflammatory therapy | 2 0.02 3.44 Antiplatelet therapy | 6 0.06 3.50 Antiviral prophylaxis | 9 0.09 3.59 Anxiety | 70 0.70 4.29 Anxiety disorder | 1 0.01 4.30 Aortic bypass | 2 0.02 4.32 Aplastic anaemia | 1 0.01 4.33 Appetite disorder | 1 0.01 4.34 Arrhythmia | 3 0.03 4.37 Arteriosclerosis | 1 0.01 4.38 Arthralgia | 22 0.22 4.60 Arthritis | 25 0.25 4.85 Arthritis reactive | 16 0.16 5.01 Arthropathy | 2 0.02 5.03 Asthenia | 5 0.05 5.08 Asthma | 111 1.11 6.19 Asthma-chronic obstructive pulmonary .. | 1 0.01 6.20 Astrocytoma, low grade | 1 0.01 6.21 Atrial fibrillation | 42 0.42 6.63 Atrial flutter | 3 0.03 6.66 Atrial tachycardia | 6 0.06 6.72 Attention deficit/hyperactivity disor.. | 35 0.35 7.07 Autoimmune disorder | 1 0.01 7.08 Autoimmune thyroiditis | 2 0.02 7.10 Autologous bone marrow transplantatio.. | 3 0.03 7.13 Autonomic nervous system imbalance | 1 0.01 7.14 B-cell lymphoma | 40 0.40 7.54 B-cell lymphoma recurrent | 1 0.01 7.55 Back injury | 3 0.03 7.58 Back pain | 27 0.27 7.85 Bacterial infection | 1 0.01 7.86 Barrett's oesophagus | 2 0.02 7.88 Basal cell carcinoma | 2 0.02 7.90 Basedow's disease | 1 0.01 7.91 Benign prostatic hyperplasia | 6 0.06 7.97 Bicytopenia | 2 0.02 7.99 Bile duct cancer | 2 0.02 8.01 Bipolar I disorder | 7 0.07 8.08 Bipolar disorder | 76 0.76 8.84 Bipolar disorder relapse prophylaxis | 4 0.04 8.88 Bladder cancer recurrent | 2 0.02 8.90 Bladder disorder | 2 0.02 8.92 Blood bilirubin increased | 1 0.01 8.93 Blood calcium decreased | 1 0.01 8.94 Blood cholesterol | 13 0.13 9.07 Blood cholesterol abnormal | 15 0.15 9.22 Blood cholesterol increased | 43 0.43 9.65 Blood disorder | 1 0.01 9.66 Blood glucose abnormal | 2 0.02 9.68 Blood glucose increased | 1 0.01 9.69 Blood iron | 1 0.01 9.70 Blood magnesium decreased | 2 0.02 9.72 Blood oestrogen decreased | 3 0.03 9.75 Blood potassium decreased | 1 0.01 9.76 Blood pressure abnormal | 21 0.21 9.97 Blood pressure decreased | 1 0.01 9.98 Blood pressure increased | 3 0.03 10.01 Blood pressure measurement | 14 0.14 10.15 Blood pressure systolic | 2 0.02 10.17 Blood pressure systolic abnormal | 1 0.01 10.18 Blood testosterone decreased | 3 0.03 10.21 Blood triglycerides | 2 0.02 10.23 Blood triglycerides increased | 5 0.05 10.28 Body height below normal | 4 0.04 10.32 Bone density decreased | 3 0.03 10.35 Bone disorder | 4 0.04 10.39 Bone giant cell tumour | 1 0.01 10.40 Bone loss | 11 0.11 10.51 Bone marrow conditioning regimen | 6 0.06 10.57 Bone marrow failure | 5 0.05 10.62 Bone pain | 5 0.05 10.67 Brain oedema | 2 0.02 10.69 Brain stem glioma | 1 0.01 10.70 Breakthrough pain | 3 0.03 10.73 Breast cancer | 65 0.65 11.38 Breast cancer female | 2 0.02 11.40 Breast cancer metastatic | 71 0.71 12.11 Breast cancer recurrent | 1 0.01 12.12 Bronchial carcinoma | 1 0.01 12.13 Bronchioloalveolar carcinoma | 1 0.01 12.14 Bronchitis | 13 0.13 12.27 Bronchitis chronic | 8 0.08 12.35 Bronchopulmonary aspergillosis | 2 0.02 12.37 Brown-Sequard syndrome | 1 0.01 12.38 Burkitt's lymphoma | 10 0.10 12.48 Burning sensation | 2 0.02 12.50 Caesarean section | 2 0.02 12.52 Calcium deficiency | 2 0.02 12.54 Carcinoid syndrome | 1 0.01 12.55 Carcinoid tumour | 5 0.05 12.60 Cardiac disorder | 28 0.28 12.88 Cardiac failure | 13 0.13 13.01 Cardiac failure chronic | 3 0.03 13.04 Cardiac failure congestive | 2 0.02 13.06 Cardiac valve disease | 1 0.01 13.07 Cardiovascular disorder | 1 0.01 13.08 Cardiovascular event prophylaxis | 37 0.37 13.45 Carpal tunnel syndrome | 2 0.02 13.47 Cataplexy | 5 0.05 13.52 Cerebral aspergillosis | 1 0.01 13.53 Cerebral haemorrhage | 4 0.04 13.57 Cerebral infarction | 2 0.02 13.59 Cerebral oedema management | 1 0.01 13.60 Cerebrovascular accident | 7 0.07 13.67 Cerebrovascular accident prophylaxis | 18 0.18 13.85 Chest pain | 5 0.05 13.90 Chills | 3 0.03 13.93 Chondropathy | 1 0.01 13.94 Choroidal neovascularisation | 1 0.01 13.95 Chronic gastritis | 2 0.02 13.97 Chronic hepatitis B | 2 0.02 13.99 Chronic hepatitis C | 23 0.23 14.22 Chronic kidney disease | 2 0.02 14.24 Chronic lymphocytic leukaemia | 20 0.20 14.44 Chronic myeloid leukaemia | 37 0.37 14.81 Chronic obstructive pulmonary disease | 70 0.70 15.51 Chronic spontaneous urticaria | 4 0.04 15.55 Clear cell renal cell carcinoma | 1 0.01 15.56 Clostridial sepsis | 6 0.06 15.62 Clostridium difficile colitis | 1 0.01 15.63 Cluster headache | 1 0.01 15.64 Colitis | 1 0.01 15.65 Colitis ulcerative | 3 0.03 15.68 Collagen disorder | 2 0.02 15.70 Colon cancer | 11 0.11 15.81 Colon cancer metastatic | 11 0.11 15.92 Colonoscopy | 1 0.01 15.93 Colorectal cancer | 14 0.14 16.07 Colorectal cancer metastatic | 32 0.32 16.39 Compression fracture | 3 0.03 16.42 Conjunctival haemorrhage | 1 0.01 16.43 Conjunctivitis allergic | 1 0.01 16.44 Constipation | 48 0.48 16.92 Constipation prophylaxis | 1 0.01 16.93 Contraception | 14 0.14 17.07 Contraceptive cap | 1 0.01 17.08 Convulsion prophylaxis | 4 0.04 17.12 Cor pulmonale chronic | 5 0.05 17.17 Coronary arterial stent insertion | 11 0.11 17.28 Coronary artery disease | 24 0.24 17.52 Cough | 7 0.07 17.59 Crohn's disease | 73 0.73 18.32 Cryopyrin associated periodic syndrome | 1 0.01 18.33 Cystic fibrosis | 9 0.09 18.42 Cytomegalovirus infection | 3 0.03 18.45 Decreased appetite | 3 0.03 18.48 Deep vein thrombosis | 8 0.08 18.56 Delirium | 1 0.01 18.57 Delusion | 2 0.02 18.59 Dementia Alzheimer's type | 4 0.04 18.63 Depressed mood | 1 0.01 18.64 Depression | 172 1.72 20.36 Depressive symptom | 1 0.01 20.37 Dermatitis acneiform | 1 0.01 20.38 Dermatitis diaper | 1 0.01 20.39 Dermatomyositis | 5 0.05 20.44 Device related infection | 2 0.02 20.46 Device therapy | 2 0.02 20.48 Diabetes insipidus | 1 0.01 20.49 Diabetes mellitus | 74 0.74 21.23 Diabetes mellitus management | 1 0.01 21.24 Diabetic nephropathy | 1 0.01 21.25 Diabetic neuropathy | 10 0.10 21.35 Diabetic retinal oedema | 1 0.01 21.36 Diarrhoea | 18 0.18 21.54 Diffuse large B-cell lymphoma | 12 0.12 21.66 Disturbance in social behaviour | 2 0.02 21.68 Diuretic therapy | 3 0.03 21.71 Diverticulitis | 2 0.02 21.73 Dizziness | 3 0.03 21.76 Drug abuse | 3 0.03 21.79 Drug therapy | 3 0.03 21.82 Drug tolerance | 2 0.02 21.84 Drug toxicity prophylaxis | 4 0.04 21.88 Drug use disorder | 3 0.03 21.91 Dry eye | 3 0.03 21.94 Dry mouth | 1 0.01 21.95 Dumping syndrome | 1 0.01 21.96 Dwarfism | 1 0.01 21.97 Dyslipidaemia | 18 0.18 22.15 Dysmenorrhoea | 2 0.02 22.17 Dyspepsia | 20 0.20 22.37 Dysphagia | 2 0.02 22.39 Dyspnoea | 19 0.19 22.58 Dyspnoea paroxysmal nocturnal | 1 0.01 22.59 Ear infection | 2 0.02 22.61 Ear neoplasm | 3 0.03 22.64 Ear pain | 1 0.01 22.65 Eating disorder | 2 0.02 22.67 Ecthyma | 1 0.01 22.68 Eczema | 4 0.04 22.72 Eczema asteatotic | 3 0.03 22.75 Embolism | 5 0.05 22.80 Embolism arterial | 1 0.01 22.81 Emotional disorder | 3 0.03 22.84 Emotional distress | 2 0.02 22.86 Emphysema | 16 0.16 23.02 End stage renal disease | 6 0.06 23.08 Endocarditis enterococcal | 2 0.02 23.10 Endometrial cancer | 14 0.14 23.24 Enteritis | 1 0.01 23.25 Enterobacter infection | 9 0.09 23.34 Enterocolitis | 3 0.03 23.37 Epilepsy | 21 0.21 23.58 Epstein-Barr virus infection | 1 0.01 23.59 Erectile dysfunction | 11 0.11 23.70 Erosive oesophagitis | 6 0.06 23.76 Escherichia infection | 7 0.07 23.83 Escherichia test positive | 1 0.01 23.84 Essential hypertension | 1 0.01 23.85 Essential thrombocythaemia | 3 0.03 23.88 Essential tremor | 2 0.02 23.90 Exposure during breast feeding | 3 0.03 23.93 Extrapyramidal disorder | 1 0.01 23.94 Eye discharge | 1 0.01 23.95 Eye disorder | 5 0.05 24.00 Eyelid ptosis | 1 0.01 24.01 Fabry's disease | 10 0.10 24.11 Factor IX deficiency | 1 0.01 24.12 Factor V Leiden mutation | 1 0.01 24.13 Factor VIII deficiency | 6 0.06 24.19 Fatigue | 2 0.02 24.21 Feeling cold | 1 0.01 24.22 Fibromyalgia | 33 0.33 24.55 Finger deformity | 1 0.01 24.56 Flatulence | 2 0.02 24.58 Fluid overload | 1 0.01 24.59 Fluid replacement | 3 0.03 24.62 Fluid retention | 6 0.06 24.68 Focal dyscognitive seizures | 1 0.01 24.69 Foetal exposure during pregnancy | 5 0.05 24.74 Folate deficiency | 1 0.01 24.75 Folliculitis | 1 0.01 24.76 Fungal infection | 6 0.06 24.82 Gait disturbance | 7 0.07 24.89 Gallbladder cancer | 2 0.02 24.91 Gastric cancer | 12 0.12 25.03 Gastric disorder | 6 0.06 25.09 Gastric hypermotility | 1 0.01 25.10 Gastric pH decreased | 2 0.02 25.12 Gastric ulcer | 7 0.07 25.19 Gastrinoma | 1 0.01 25.20 Gastritis | 10 0.10 25.30 Gastritis prophylaxis | 4 0.04 25.34 Gastroenteritis | 2 0.02 25.36 Gastrointestinal disorder | 3 0.03 25.39 Gastrointestinal haemorrhage | 2 0.02 25.41 Gastrointestinal motility disorder | 1 0.01 25.42 Gastrointestinal stromal tumour | 1 0.01 25.43 Gastrointestinal tract irritation | 2 0.02 25.45 Gastrooesophageal reflux disease | 119 1.19 26.64 Gaucher's disease | 3 0.03 26.67 Generalised anxiety disorder | 2 0.02 26.69 Generalised tonic-clonic seizure | 2 0.02 26.71 Genital neoplasm malignant female | 4 0.04 26.75 Gigantism | 1 0.01 26.76 Glaucoma | 17 0.17 26.93 Glioblastoma | 5 0.05 26.98 Glioblastoma multiforme | 3 0.03 27.01 Glomerulonephritis | 1 0.01 27.02 Glomerulonephritis membranoproliferat.. | 1 0.01 27.03 Glucose tolerance impaired | 2 0.02 27.05 Glycogen storage disease type II | 6 0.06 27.11 Gout | 12 0.12 27.23 Graft versus host disease | 3 0.03 27.26 Granuloma | 1 0.01 27.27 Growth hormone deficiency | 21 0.21 27.48 Growth retardation | 2 0.02 27.50 HER-2 positive breast cancer | 13 0.13 27.63 HIV infection | 50 0.50 28.13 Haematotoxicity | 1 0.01 28.14 Haematuria | 1 0.01 28.15 Haemochromatosis | 3 0.03 28.18 Haemolytic uraemic syndrome | 8 0.08 28.26 Haemoptysis | 1 0.01 28.27 Haemorrhage | 1 0.01 28.28 Haemorrhoids | 1 0.01 28.29 Hair disorder | 3 0.03 28.32 Hairy cell leukaemia | 1 0.01 28.33 Hallucination | 2 0.02 28.35 Head and neck cancer | 3 0.03 28.38 Head and neck cancer metastatic | 3 0.03 28.41 Headache | 14 0.14 28.55 Heart rate abnormal | 1 0.01 28.56 Heart rate irregular | 1 0.01 28.57 Heart valve replacement | 1 0.01 28.58 Helicobacter infection | 1 0.01 28.59 Hepatic cirrhosis | 1 0.01 28.60 Hepatic function abnormal | 4 0.04 28.64 Hepatitis B | 3 0.03 28.67 Hepatitis C | 38 0.38 29.05 Hepatitis cholestatic | 1 0.01 29.06 Hepatobiliary disease | 1 0.01 29.07 Hepatocellular carcinoma | 6 0.06 29.13 Hereditary motor and sensory neuropathy | 1 0.01 29.14 Herpes zoster | 11 0.11 29.25 Herpes zoster oticus | 5 0.05 29.30 Hiatus hernia | 17 0.17 29.47 Hip arthroplasty | 1 0.01 29.48 Histiocytosis haematophagic | 1 0.01 29.49 Hodgkin's disease | 10 0.10 29.59 Hormone replacement therapy | 2 0.02 29.61 Hormone-refractory prostate cancer | 3 0.03 29.64 Hot flush | 3 0.03 29.67 Huntington's disease | 1 0.01 29.68 Hyperchlorhydria | 4 0.04 29.72 Hypercholesterolaemia | 12 0.12 29.84 Hypereosinophilic syndrome | 1 0.01 29.85 Hyperglycaemia | 4 0.04 29.89 Hyperinsulinaemic hypoglycaemia | 1 0.01 29.90 Hyperlipidaemia | 24 0.24 30.14 Hyperparathyroidism secondary | 1 0.01 30.15 Hypersensitivity | 14 0.14 30.29 Hypertension | 268 2.68 32.97 Hypertonic bladder | 3 0.03 33.00 Hypertrophic cardiomyopathy | 3 0.03 33.03 Hyperuricaemia | 14 0.14 33.17 Hypoaesthesia | 2 0.02 33.19 Hypocalcaemia | 1 0.01 33.20 Hypoglycaemia | 1 0.01 33.21 Hypokalaemia | 3 0.03 33.24 Hypokalaemic syndrome | 1 0.01 33.25 Hypomagnesaemia | 1 0.01 33.26 Hypopharyngeal cancer | 7 0.07 33.33 Hypopituitarism | 9 0.09 33.42 Hypothalamo-pituitary disorder | 1 0.01 33.43 Hypothyroidism | 41 0.41 33.84 Hypovitaminosis | 5 0.05 33.89 Hypoxia | 1 0.01 33.90 Idiopathic generalised epilepsy | 2 0.02 33.92 Ill-defined disorder | 1 0.01 33.93 Immune enhancement therapy | 1 0.01 33.94 Immune reconstitution inflammatory sy.. | 1 0.01 33.95 Immune thrombocytopenic purpura | 7 0.07 34.02 Immune-mediated necrotising myopathy | 3 0.03 34.05 Immunisation | 1 0.01 34.06 Immunodeficiency | 1 0.01 34.07 Immunosuppressant drug therapy | 7 0.07 34.14 Immunosuppression | 4 0.04 34.18 Induced labour | 1 0.01 34.19 Infantile spasms | 3 0.03 34.22 Infarction | 1 0.01 34.23 Infection | 8 0.08 34.31 Infection prophylaxis | 21 0.21 34.52 Inflammation | 3 0.03 34.55 Inflammatory bowel disease | 6 0.06 34.61 Inflammatory pain | 1 0.01 34.62 Influenza | 5 0.05 34.67 Influenza immunisation | 2 0.02 34.69 Insomnia | 45 0.45 35.14 Intermittent explosive disorder | 11 0.11 35.25 Interstitial lung disease | 5 0.05 35.30 Intervertebral disc degeneration | 3 0.03 35.33 Intervertebral disc protrusion | 2 0.02 35.35 Intestinal obstruction | 2 0.02 35.37 Intraocular pressure increased | 5 0.05 35.42 Invasive ductal breast carcinoma | 2 0.02 35.44 Iron deficiency | 1 0.01 35.45 Iron deficiency anaemia | 5 0.05 35.50 Irritability | 1 0.01 35.51 Irritable bowel syndrome | 1 0.01 35.52 Ischaemia | 2 0.02 35.54 Ischaemic cardiomyopathy | 1 0.01 35.55 Ischaemic stroke | 4 0.04 35.59 Joint arthroplasty | 1 0.01 35.60 Joint injection | 1 0.01 35.61 Juvenile idiopathic arthritis | 4 0.04 35.65 Klebsiella infection | 1 0.01 35.66 Knee arthroplasty | 3 0.03 35.69 Knee operation | 1 0.01 35.70 Labour induction | 2 0.02 35.72 Latent tuberculosis | 1 0.01 35.73 Laxative supportive care | 1 0.01 35.74 Leukaemia | 1 0.01 35.75 Leukopenia | 3 0.03 35.78 Limb discomfort | 1 0.01 35.79 Lipids increased | 3 0.03 35.82 Liver disorder | 4 0.04 35.86 Liver transplant | 7 0.07 35.93 Liver transplant rejection | 3 0.03 35.96 Localised oedema | 1 0.01 35.97 Low density lipoprotein increased | 2 0.02 35.99 Lower respiratory tract congestion | 2 0.02 36.01 Lower respiratory tract infection | 1 0.01 36.02 Lung carcinoma cell type unspecified .. | 1 0.01 36.03 Lung disorder | 3 0.03 36.06 Lung neoplasm malignant | 4 0.04 36.10 Lung transplant | 1 0.01 36.11 Lupus nephritis | 28 0.28 36.39 Lupus-like syndrome | 1 0.01 36.40 Lymphangioleiomyomatosis | 1 0.01 36.41 Lymphocytic lymphoma | 6 0.06 36.47 Lymphoma | 12 0.12 36.59 Lymphoproliferative disorder | 1 0.01 36.60 Major depression | 13 0.13 36.73 Malaise | 2 0.02 36.75 Malignant melanoma | 32 0.32 37.07 Malignant melanoma stage III | 1 0.01 37.08 Malignant neoplasm of eye | 3 0.03 37.11 Malignant neoplasm of islets of Lange.. | 1 0.01 37.12 Malignant peritoneal neoplasm | 4 0.04 37.16 Malignant pleural effusion | 1 0.01 37.17 Mania | 1 0.01 37.18 Mantle cell lymphoma | 19 0.19 37.37 Mastitis | 6 0.06 37.43 Maternal exposure timing unspecified | 8 0.08 37.51 Median nerve injury | 1 0.01 37.52 Memory impairment | 1 0.01 37.53 Menopause | 4 0.04 37.57 Menstrual discomfort | 1 0.01 37.58 Mental disorder | 5 0.05 37.63 Metabolic disorder | 1 0.01 37.64 Metaplastic breast carcinoma | 4 0.04 37.68 Metastases to bone | 14 0.14 37.82 Metastases to kidney | 1 0.01 37.83 Metastases to liver | 2 0.02 37.85 Metastases to lung | 1 0.01 37.86 Metastases to lymph nodes | 1 0.01 37.87 Metastases to meninges | 1 0.01 37.88 Metastases to pancreas | 1 0.01 37.89 Metastases to peritoneum | 4 0.04 37.93 Metastatic gastric cancer | 3 0.03 37.96 Metastatic malignant melanoma | 27 0.27 38.23 Metastatic renal cell carcinoma | 110 1.10 39.33 Microscopic polyangiitis | 1 0.01 39.34 Migraine | 8 0.08 39.42 Migraine prophylaxis | 1 0.01 39.43 Mineral supplementation | 7 0.07 39.50 Mood swings | 2 0.02 39.52 Movement disorder | 1 0.01 39.53 Mucopolysaccharidosis II | 3 0.03 39.56 Mucopolysaccharidosis VI | 1 0.01 39.57 Mucosal infection | 1 0.01 39.58 Mucosal inflammation | 2 0.02 39.60 Multiple allergies | 8 0.08 39.68 Multiple organ dysfunction syndrome | 1 0.01 39.69 Multiple sclerosis | 134 1.34 41.03 Multiple sclerosis relapse | 1 0.01 41.04 Muscle relaxant therapy | 4 0.04 41.08 Muscle spasms | 15 0.15 41.23 Muscle spasticity | 2 0.02 41.25 Musculoskeletal pain | 2 0.02 41.27 Musculoskeletal stiffness | 1 0.01 41.28 Myalgia | 3 0.03 41.31 Myelodysplastic syndrome | 7 0.07 41.38 Myelofibrosis | 15 0.15 41.53 Myeloid leukaemia | 6 0.06 41.59 Myeloproliferative neoplasm | 1 0.01 41.60 Myocardial infarction | 8 0.08 41.68 Myocardial ischaemia | 12 0.12 41.80 Myopathy | 5 0.05 41.85 Myositis | 1 0.01 41.86 Myotonia | 1 0.01 41.87 Nail disorder | 3 0.03 41.90 Narcolepsy | 7 0.07 41.97 Nasal congestion | 1 0.01 41.98 Nasopharyngitis | 2 0.02 42.00 Nausea | 26 0.26 42.26 Neck pain | 1 0.01 42.27 Neoplasm | 10 0.10 42.37 Neoplasm malignant | 1 0.01 42.38 Neoplasm progression | 2 0.02 42.40 Neoplasm prophylaxis | 1 0.01 42.41 Neovascular age-related macular degen.. | 2 0.02 42.43 Nephrogenic anaemia | 4 0.04 42.47 Nephrotic syndrome | 19 0.19 42.66 Nerve compression | 5 0.05 42.71 Nerve injury | 3 0.03 42.74 Neuralgia | 11 0.11 42.85 Neuritis | 1 0.01 42.86 Neuroendocrine carcinoma | 8 0.08 42.94 Neuroendocrine tumour | 8 0.08 43.02 Neuromuscular pain | 1 0.01 43.03 Neuropathy peripheral | 16 0.16 43.19 Neutropenia | 7 0.07 43.26 Neutropenic sepsis | 4 0.04 43.30 Nicotine dependence | 1 0.01 43.31 Niemann-Pick disease | 4 0.04 43.35 Night sweats | 2 0.02 43.37 Non-Hodgkin's lymphoma | 5 0.05 43.42 Non-small cell lung cancer | 40 0.40 43.82 Nuclear magnetic resonance imaging th.. | 1 0.01 43.83 Nutritional supplementation | 6 0.06 43.89 Nystagmus | 1 0.01 43.90 Obsessive-compulsive disorder | 2 0.02 43.92 Oedema | 6 0.06 43.98 Oedema peripheral | 4 0.04 44.02 Oesophageal adenocarcinoma | 3 0.03 44.05 Oesophageal carcinoma | 2 0.02 44.07 Oesophagitis | 1 0.01 44.08 Oestrogen therapy | 1 0.01 44.09 Off label use | 7 0.07 44.16 Onychomycosis | 1 0.01 44.17 Opportunistic infection prophylaxis | 1 0.01 44.18 Oppositional defiant disorder | 19 0.19 44.37 Oral fungal infection | 2 0.02 44.39 Oral herpes | 1 0.01 44.40 Oral pain | 1 0.01 44.41 Oropharyngeal cancer | 3 0.03 44.44 Orthostatic hypotension | 1 0.01 44.45 Osteitis deformans | 6 0.06 44.51 Osteoarthritis | 14 0.14 44.65 Osteomyelitis | 2 0.02 44.67 Osteonecrosis | 2 0.02 44.69 Osteopenia | 163 1.63 46.32 Osteoporosis | 443 4.43 50.75 Osteoporosis postmenopausal | 6 0.06 50.81 Osteoporosis prophylaxis | 28 0.28 51.09 Ovarian cancer | 9 0.09 51.18 Ovarian epithelial cancer | 8 0.08 51.26 Pain | 146 1.46 52.72 Pain in extremity | 6 0.06 52.78 Pain management | 8 0.08 52.86 Palmar-plantar erythrodysaesthesia sy.. | 2 0.02 52.88 Palpitations | 1 0.01 52.89 Pancreas transplant | 1 0.01 52.90 Pancreatic neuroendocrine tumour | 23 0.23 53.13 Pancreatitis chronic | 1 0.01 53.14 Panic attack | 4 0.04 53.18 Panic disorder | 2 0.02 53.20 Parkinson's disease | 18 0.18 53.38 Parkinsonism | 1 0.01 53.39 Paroxysmal nocturnal haemoglobinuria | 17 0.17 53.56 Partial seizures | 4 0.04 53.60 Patient restraint | 2 0.02 53.62 Pemphigus | 1 0.01 53.63 Peptic ulcer | 1 0.01 53.64 Pericardial effusion | 1 0.01 53.65 Pericarditis | 1 0.01 53.66 Peripheral arterial occlusive disease | 1 0.01 53.67 Peripheral vascular disorder | 1 0.01 53.68 Peritoneal dialysis | 3 0.03 53.71 Persistent depressive disorder | 2 0.02 53.73 Pharyngitis | 2 0.02 53.75 Phenylketonuria | 3 0.03 53.78 Pineal germinoma | 9 0.09 53.87 Pituitary tumour benign | 3 0.03 53.90 Plasma cell myeloma | 68 0.68 54.58 Plasmacytoma | 1 0.01 54.59 Plasmodium vivax infection | 3 0.03 54.62 Pneumocystis jirovecii pneumonia | 3 0.03 54.65 Pneumonia | 16 0.16 54.81 Pneumonia aspiration | 4 0.04 54.85 Pneumonia fungal | 3 0.03 54.88 Pneumonia pseudomonal | 1 0.01 54.89 Pneumonia respiratory syncytial viral | 2 0.02 54.91 Pneumonia staphylococcal | 1 0.01 54.92 Pneumonia viral | 1 0.01 54.93 Pneumoperitoneum | 1 0.01 54.94 Pollakiuria | 2 0.02 54.96 Polycythaemia vera | 1 0.01 54.97 Polymyalgia rheumatica | 1 0.01 54.98 Polymyositis | 1 0.01 54.99 Polyomavirus-associated nephropathy | 1 0.01 55.00 Polypoidal choroidal vasculopathy | 4 0.04 55.04 Polyuria | 2 0.02 55.06 Poor quality sleep | 1 0.01 55.07 Post herpetic neuralgia | 1 0.01 55.08 Post-traumatic pain | 1 0.01 55.09 Post-traumatic stress disorder | 23 0.23 55.32 Postmenopause | 2 0.02 55.34 Postoperative care | 1 0.01 55.35 Postpartum haemorrhage | 1 0.01 55.36 Prader-Willi syndrome | 2 0.02 55.38 Pre-eclampsia | 1 0.01 55.39 Premedication | 71 0.71 56.10 Preoperative hormone treatment | 1 0.01 56.11 Primary immunodeficiency syndrome | 1 0.01 56.12 Primary myelofibrosis | 1 0.01 56.13 Probiotic therapy | 1 0.01 56.14 Procedural pain | 3 0.03 56.17 Product used for unknown indication | 2,634 26.34 82.51 Prophylaxis | 179 1.79 84.30 Prophylaxis against diarrhoea | 1 0.01 84.31 Prophylaxis against gastrointestinal .. | 13 0.13 84.44 Prophylaxis against graft versus host.. | 7 0.07 84.51 Prophylaxis against transplant reject.. | 26 0.26 84.77 Prophylaxis of nausea and vomiting | 3 0.03 84.80 Prostate cancer | 13 0.13 84.93 Prostate cancer metastatic | 3 0.03 84.96 Prostate cancer stage IV | 5 0.05 85.01 Prostatectomy | 2 0.02 85.03 Prostatic disorder | 1 0.01 85.04 Prostatic specific antigen | 1 0.01 85.05 Prostatic specific antigen increased | 2 0.02 85.07 Prostatomegaly | 3 0.03 85.10 Pruritus | 1 0.01 85.11 Pseudomembranous colitis | 1 0.01 85.12 Pseudoxanthoma elasticum | 1 0.01 85.13 Psoriasis | 74 0.74 85.87 Psoriatic arthropathy | 28 0.28 86.15 Psychiatric symptom | 6 0.06 86.21 Psychomotor hyperactivity | 1 0.01 86.22 Psychotic disorder | 41 0.41 86.63 Pulmonary arterial hypertension | 38 0.38 87.01 Pulmonary embolism | 1 0.01 87.02 Pulmonary fibrosis | 1 0.01 87.03 Pulmonary hypertension | 47 0.47 87.50 Pulmonary tuberculosis | 3 0.03 87.53 Pulse abnormal | 1 0.01 87.54 Pupil dilation procedure | 2 0.02 87.56 Pustular psoriasis | 1 0.01 87.57 Pyelonephritis | 4 0.04 87.61 Pyrexia | 23 0.23 87.84 Rash | 5 0.05 87.89 Raynaud's phenomenon | 2 0.02 87.91 Rectal adenocarcinoma | 10 0.10 88.01 Rectal cancer | 8 0.08 88.09 Reflux gastritis | 4 0.04 88.13 Relapsing-remitting multiple sclerosis | 18 0.18 88.31 Relaxation therapy | 1 0.01 88.32 Renal cancer | 5 0.05 88.37 Renal cancer recurrent | 1 0.01 88.38 Renal cell carcinoma | 16 0.16 88.54 Renal disorder | 1 0.01 88.55 Renal impairment | 1 0.01 88.56 Renal scan | 1 0.01 88.57 Renal transplant | 26 0.26 88.83 Respiratory disorder | 1 0.01 88.84 Respiratory distress | 1 0.01 88.85 Respiratory syncytial virus infection | 2 0.02 88.87 Respiratory therapy | 1 0.01 88.88 Respiratory tract congestion | 1 0.01 88.89 Restless legs syndrome | 8 0.08 88.97 Restlessness | 1 0.01 88.98 Retinal haemorrhage | 2 0.02 89.00 Retroperitoneal fibrosis | 1 0.01 89.01 Rheumatoid arthritis | 271 2.71 91.72 Rhinitis allergic | 1 0.01 91.73 Rhinovirus infection | 2 0.02 91.75 Routine health maintenance | 8 0.08 91.83 Schizoaffective disorder | 37 0.37 92.20 Schizoaffective disorder bipolar type | 3 0.03 92.23 Schizophrenia | 202 2.02 94.25 Sciatica | 2 0.02 94.27 Scleroderma associated digital ulcer | 1 0.01 94.28 Sclerotherapy | 1 0.01 94.29 Scoliosis | 2 0.02 94.31 Seasonal allergy | 2 0.02 94.33 Seborrhoeic dermatitis | 1 0.01 94.34 Secondary progressive multiple sclero.. | 1 0.01 94.35 Sedation | 3 0.03 94.38 Sedative therapy | 1 0.01 94.39 Seizure | 30 0.30 94.69 Senile osteoporosis | 1 0.01 94.70 Sepsis | 6 0.06 94.76 Sexual dysfunction | 2 0.02 94.78 Shunt thrombosis | 1 0.01 94.79 Sickle cell anaemia | 2 0.02 94.81 Sinus disorder | 1 0.01 94.82 Sinusitis | 3 0.03 94.85 Sjogren's syndrome | 3 0.03 94.88 Skin cancer | 1 0.01 94.89 Skin disorder | 3 0.03 94.92 Skin fragility | 1 0.01 94.93 Skin toxicity | 1 0.01 94.94 Skin ulcer | 3 0.03 94.97 Sleep apnoea syndrome | 1 0.01 94.98 Sleep disorder | 27 0.27 95.25 Small cell lung cancer | 2 0.02 95.27 Smoking cessation therapy | 7 0.07 95.34 Sneezing | 1 0.01 95.35 Somatic symptom disorder | 2 0.02 95.37 Somnolence | 1 0.01 95.38 Spinal anaesthesia | 3 0.03 95.41 Spinal disorder | 2 0.02 95.43 Spinal pain | 7 0.07 95.50 Spondylitis | 1 0.01 95.51 Squamous cell carcinoma of head and n.. | 3 0.03 95.54 Status epilepticus | 17 0.17 95.71 Stem cell transplant | 4 0.04 95.75 Stent placement | 9 0.09 95.84 Still's disease | 12 0.12 95.96 Stomatitis | 3 0.03 95.99 Stress | 1 0.01 96.00 Stress at work | 4 0.04 96.04 Substance abuse | 1 0.01 96.05 Substance dependence | 1 0.01 96.06 Substance use | 1 0.01 96.07 Suicide attempt | 8 0.08 96.15 Supplementation therapy | 17 0.17 96.32 Supraventricular tachycardia | 1 0.01 96.33 Swelling | 2 0.02 96.35 Syncope | 1 0.01 96.36 Systemic lupus erythematosus | 15 0.15 96.51 Systemic sclerosis pulmonary | 1 0.01 96.52 T-cell depletion | 1 0.01 96.53 Tachycardia | 3 0.03 96.56 Tardive dyskinesia | 1 0.01 96.57 Tendonitis | 1 0.01 96.58 Tension | 1 0.01 96.59 Testicular pain | 3 0.03 96.62 Throat cancer | 3 0.03 96.65 Thrombocytopenia | 1 0.01 96.66 Thrombophlebitis | 1 0.01 96.67 Thrombosis | 3 0.03 96.70 Thrombosis prophylaxis | 30 0.30 97.00 Thyroid cancer | 4 0.04 97.04 Thyroid disorder | 17 0.17 97.21 Thyroid hormone replacement therapy | 1 0.01 97.22 Thyroid mass | 1 0.01 97.23 Thyroid stimulating hormone-producing.. | 1 0.01 97.24 Thyroid therapy | 1 0.01 97.25 Thyroidectomy | 2 0.02 97.27 Tobacco abuse | 1 0.01 97.28 Tobacco user | 1 0.01 97.29 Torticollis | 3 0.03 97.32 Tourette's disorder | 14 0.14 97.46 Transfusion | 1 0.01 97.47 Transgender hormonal therapy | 2 0.02 97.49 Transgender operation | 1 0.01 97.50 Transient ischaemic attack | 1 0.01 97.51 Transitional cell carcinoma | 2 0.02 97.53 Transplant | 6 0.06 97.59 Transplant rejection | 1 0.01 97.60 Trigeminal neuralgia | 1 0.01 97.61 Tumour pain | 3 0.03 97.64 Turner's syndrome | 2 0.02 97.66 Type 1 diabetes mellitus | 14 0.14 97.80 Type 2 diabetes mellitus | 133 1.33 99.13 Type IIa hyperlipidaemia | 1 0.01 99.14 Unintended pregnancy | 1 0.01 99.15 Upper respiratory tract infection | 2 0.02 99.17 Upper respiratory tract inflammation | 1 0.01 99.18 Urinary incontinence | 2 0.02 99.20 Urinary tract infection | 2 0.02 99.22 Urticaria chronic | 2 0.02 99.24 Uterine cancer | 2 0.02 99.26 Uveitis | 3 0.03 99.29 Vein disorder | 1 0.01 99.30 Venous thrombosis | 1 0.01 99.31 Ventricular extrasystoles | 4 0.04 99.35 Ventricular tachycardia | 4 0.04 99.39 Vertigo | 1 0.01 99.40 Vertigo positional | 1 0.01 99.41 Viral diarrhoea | 1 0.01 99.42 Viral upper respiratory tract infection | 2 0.02 99.44 Vitamin D decreased | 2 0.02 99.46 Vitamin D deficiency | 3 0.03 99.49 Vitamin supplementation | 18 0.18 99.67 Vomiting | 15 0.15 99.82 Vulvovaginal dryness | 3 0.03 99.85 Vulvovaginal pruritus | 2 0.02 99.87 Weight control | 2 0.02 99.89 Weight decreased | 2 0.02 99.91 Weight increased | 1 0.01 99.92 Wheezing | 6 0.06 99.98 Withdrawal syndrome | 1 0.01 99.99 Wound infection | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Jun 2018